Chinese security official Zhu Jiabin earned the nickname “The Butcher” over allegations that he coldly slaughtered imprisoned religious minorities and removed their organs for transplant.
“After slaughtering and opening up the belly, you just carve out the organs and sell them… It is nothing – just like slaughtering pigs,” he reportedly said, describing how he removed body parts from prisoners.
“You come over to shave their hair first and then split open the belly. I would carve out whatever I need. After scooping the organs out, I would sell them,” the official allegedly boasted in a phone conversation.
Zhu was said to be part of an organ-harvesting system in which tens of thousands of prisoners were forcibly killed for their organs, fuelling a trade estimated to have generated $1 billion a year since 2000.
Many alleged victims were Falun Gong practitioners and other prisoners of conscience, who were killed during the transplant process.
China said it banned the practice in 2015 and would instead rely on a national organ-donation system.
However, a new report claims that more than 100 doctors and surgeons previously linked to the forced harvesting of organs from prisoners – including prisoners who were still alive – continue to work in China.
Rather than facing investigation or known professional sanctions, many appear to have advanced through the medical system and taken senior positions in thoracic surgery.
In many cases, the medical professionals identified in the original 2022 study now serve as senior physicians, transplant-centre directors and prominent figures in the international transplant community
Members of the Uyghur ethnic minority are pictured in a camp in Lop County, Xinjiang, in April 2017
For years before the reported ban, China relied heavily on prisoners to provide the vast majority of organs used for transplants.
Witnesses said the operations targeted healthy detainees, often aged 28 or 29. After undergoing medical examinations and blood tests, some were reportedly “cross-matched for harvesting”.
A week later, those selected allegedly “vanished in the middle of the night”, according to Ethan Gutmann of the Victims of Communism Memorial Foundation.
In 2022, the world’s leading transplant journal published findings that raised serious questions about the foundations of China’s transplant industry.
The American Journal of Transplantation reviewed Chinese clinical papers published between 1980 and 2015. It found descriptions of heart and lung procurement suggesting that some donors had not been properly declared brain dead before their vital organs were removed – a violation of the Dead Donor Rule.
Human rights groups now fear that forced organ harvesting from living patients may still be taking place, despite Beijing’s denials.
A November report from the International Coalition to End Transplant Abuse in China, known as ETAC, says doctors whose published research documents alleged breaches of the Dead Donor Rule continue to hold positions of influence. They train younger surgeons, contribute to international research and attend major global conferences.
In many cases, the medical professionals identified in the 2022 study by Matthew P. Robertson and Jacob Lavee are now senior doctors, transplant-centre directors and prominent members of the international transplant community.
Robertson and Lavee reviewed 71 clinical papers and identified 56 hospitals in 15 provinces linked to the disputed procedures between 1980 and 2015. The papers described organ procurement operations in which donors were allegedly killed.
ETAC says more than 100 of the doctors linked to those papers were still working at 40 hospitals across 16 provinces in 2025.
Sarah Cook, author of the ETAC report, told the Daily Mail: “The Dead Donor Rule is a foundational principle of transplant medicine to separate transplant surgery from killing.
“That red line was breached repeatedly in China, and many of those doctors are still working.
“The hospitals employing these doctors span more than half of China’s provinces and include leading transplant centres.
“This is not a fringe problem confined to a small number of institutions that can be swept under the rug.
“The past violations of the Dead Donor Rule identified in the 2022 paper form a systemic foundation that remains integral to China’s transplant sector today.”
Foreign medical and human rights organisations have long criticised China’s organ-transplant system as opaque, commercially driven and unethical.
The latest findings challenge Beijing’s claims that the system has been reformed and highlight continuing concerns over state-sanctioned forced organ harvesting, including the killing of prisoners and prisoners of conscience to meet demand for organs.
An independent tribunal convened in London concluded in 2019 that detainees were still being killed for organ transplants. It said victims included imprisoned followers of Falun Gong.
Persecution of the movement began in 1999, after it attracted tens of millions of followers and was viewed by the Chinese Communist Party as a threat.
Although Falun Gong practitioners were historically considered the country’s main source of organs, the China Tribunal said Uyghurs were undergoing medical testing on a scale that could enable them to become an “organ bank”.
The tribunal, chaired by Sir Geoffrey Nice KC, also alleged that China may have systematically falsified its organ-donation figures.
It concluded that as many as 100,000 transplants could have been carried out in China each year – almost three times the number reported by the government to the international registry.
Sayragul Sauytbay, a Kazakh doctor detained in Xinjiang in 2017, has described camp-wide “health checks” during which prisoners had their blood tested and were sorted according to the results.
She said people marked with a pink check would soon disappear, leading her to conclude that they had been selected for “organ harvesting”.
According to the Council on Foreign Relations, the Chinese government has imprisoned more than one million Uyghurs since 2017. Those who remain outside detention have faced extensive surveillance, restrictions on religious practice, forced labour, family separation and forced sterilisation.
The United States declared in 2021 that China’s actions amounted to genocide. A later United Nations report said they could constitute crimes against humanity.
Beijing has also been accused of supplying organs to wealthy recipients prepared to pay tens or even hundreds of thousands of pounds.
A kidney-transplant patient who testified to the tribunal said he paid RMB350,000 (£38,500) for the organ, RMB86,000 (£9,800) for the surgery and RMB50,000 (£5,700) as a “bonus” for the doctor. The total cost was RMB486,000 (£53,500).
Kidneys, however, are not among the most expensive organs.
Jennifer Zeng, a Falun Gong activist, spent a year in a women’s labour camp before fleeing China in 2001.
In evidence to the tribunal, she said: “Inmates of the labour camp were not allowed to exchange contact details, so there was no way to trace each other after we were released. When anyone disappeared from the camp, I would assume that she was released and had gone home.
“But in reality that cannot be confirmed, as I had no way to trace others after my release. I now fear they might have been taken to a hospital, had their organs removed without consent and been killed in the process.”
CHECK THIS OUT: Susan Smith’s Ex-Husband David Smith Opposes Parole, Says She Should Die in Prison for Drowning Their Sons
Experts raised fresh concerns last summer after reports emerged that the Xinjiang Health Commission, part of China’s national health authority, planned to open six new medical centres by 2030.
The expansion would take the region’s total number of facilities to nine.
Given the history of abuses against the Uyghur population – estimated at 10 million in Xinjiang – campaigners fear the new transplant centres could increase the risk of forced organ harvesting.
Xinjiang has a smaller population and lower organ-donation rate than many other Chinese provinces, making the planned expansion a source of concern.
The new centres would give Xinjiang nine organ-transplant facilities for a population of approximately 26 million.
By comparison, Guizhou province has about 39 million residents but only three such facilities.
Leading Chinese heart-transplant surgeon Dong Nianguo performs an operation at Wuhan Union Hospital in January 2024. Dong is also a CCP member and co-author of two clinical papers that indicate possible violations of the Dead Donor Rule
A leading Chinese transplant doctor acknowledged in 2007 that “effectively 95 per cent of all organ transplants were from prisoners”, Robertson and Lavee wrote in their landmark study.
Among the authors identified in 2022, the researchers found 53 recurring names that appeared on at least two papers describing alleged violations of the Dead Donor Rule.
ETAC described these doctors as being of “particular concern”.
A single paper containing a problematic declaration of brain death could, in theory, reflect limited involvement in one procedure, although co-authorship would still indicate awareness of the practice.
But repeated appearances across several papers, sometimes over a number of years, suggest ongoing participation in or acceptance of procurement procedures that breached the Dead Donor Rule.
Of the 53 recurring authors, 39 have confirmed current institutional affiliations.
Those 39 medical professionals, most of them surgeons, are now spread across 13 hospitals in five provinces and municipalities in eastern and central China, including Hubei, Anhui, Guangdong, Shanghai and Jiangsu.
Some of the authors appeared on five or six of the disputed papers.
ETAC said many are now department heads, professors or senior transplant surgeons at some of China’s most prominent medical institutions.
Wuhan Union Hospital, part of Tongji Medical College at Huazhong University of Science and Technology, is one of China’s leading academic medical centres. Its cardiovascular surgery department has long been among the country’s busiest transplant programmes.
Seven named doctors from the department appear in disputed papers published between 1995 and 2005. Nearly all remain active in senior positions, including Dong Nianguo, one of China’s best-known heart-transplant surgeons.
In 2024, Dong hosted the 32nd annual meeting of the Asian Society for Cardiovascular and Thoracic Surgery in Wuhan while serving as the association’s rotating president.
The event took place two years after Robertson and Lavee published their study.
An online invitation signed by Dong referred to planned cooperation with the American Association for Thoracic Surgery (AATS) and the European Association for Cardio-Thoracic Surgery (EACTS). His signature also identified him as an AATS member.
The career of Hu Bin, of Beijing Chaoyang Hospital, is also notable.
Hu appeared in a disputed paper published in 2006. He is now the hospital’s department director, a graduate supervisor, a CCP member and Party Branch Secretary of thoracic surgery.
A July 2024 document named him among 100 “outstanding” CCP members working in Beijing’s health sector.
He is also a council member of the Organ Transplantation Subspecialty Physicians Branch of the Beijing Medical Association, a professional body responsible for promoting standards in the field.
He Jianxing, of the First Affiliated Hospital of Guangzhou Medical University, was listed as an author on six of the 71 disputed papers, published between 2006 and 2010.
He is now a leading figure in Chinese thoracic and transplant surgery and has an extensive international publication record.
An article published in April 2022 to mark the 28th anniversary of his career identified him as a member of both the AATS and EACTS.
Cheng Xiangyang appeared on four disputed papers between 2006 and 2010.
A March 2026 article listed the doctor’s memberships of the International Association for the Study of Lung Cancer (IASLC), the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO).
Cook told the Daily Mail: “If the Chinese government wants to demonstrate that it is serious about reform, it must acknowledge and investigate past ethical violations.
“Chinese health authorities, transplant professionals and organisations, including the Chinese Medical Association and its Organ Transplantation branch, should recognise the findings of the 2022 Robertson-Lavee paper.
“They should commission a genuinely independent investigation into breaches of the Dead Donor Rule, publish the findings and impose penalties on responsible doctors in line with Chinese law, medical-association guidance and international standards.”
ETAC stressed that authorship of a peer-reviewed clinical paper does not necessarily prove that every listed co-author took part in the procedures described.
Nevertheless, the report said, being named as an author amounts to a “professional endorsement of its contents”.
“At a minimum, named authors were aware of and publicly associated themselves with the procurement practices described.
“Whether every author was physically present for every procedure, association with a paper describing problematic declarations of brain death is itself a serious breach of professional ethics.
“Chinese physicians documented in a peer-reviewed study as having violated the Dead Donor Rule, or condoned its violation, remain active in the medical system,” it concluded.
ETAC has urged governments to consider visa policies that could bar entry to foreign nationals involved in organ trafficking or coerced transplantation.
The organisation also called for targeted sanctions, including asset freezes, against Chinese officials and others where credible evidence shows they authorised, directed, facilitated, participated in or knowingly enabled forced organ harvesting or related organ trafficking.
Beijing has repeatedly said it follows international medical standards, which require organ donations to be voluntary and free from financial incentives.
The Chinese government has dismissed international allegations of wrongdoing as politically motivated and false.